Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
8.24
+0.16 (1.98%)
At close: Nov 3, 2025, 4:00 PM EST
8.30
+0.06 (0.73%)
After-hours: Nov 3, 2025, 7:47 PM EST
Genelux Market Cap
Genelux has a market cap or net worth of $307.68 million as of November 3, 2025. Its market cap has increased by 221.08% in one year.
Market Cap
307.68M
Enterprise Value
281.42M
1-Year Change
221.08%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has increased from $141.69M to $307.68M, an increase of 117.15%. That is a compound annual growth rate of 32.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 307.68M | 282.27% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.59B |
| Johnson & Johnson | 455.04B |
| AbbVie | 385.18B |
| UnitedHealth Group | 309.40B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 214.96B |